BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 450519 NC1(C(=O)Nc2nc(ncc12)-c1nn(Cc2ccccc2F)c2ncccc12)C(F)(F)F InChI=1S/C20H13F4N7O/c21-13-6-2-1-4-10(13)9-31-17-11(5-3-7-26-17)14(30-31)16-27-8-12-15(28-16)29-18(32)19(12,25)20(22,23)24/h1-8H,9,25H2,(H,27,28,29,32) XHKGQVRZYLFELL-UHFFFAOYSA-N 258363 US9505786, 1 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1200 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258363&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621366 374883738 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450520 CCOC(=O)C1(C)CC(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H20FN7O3/c1-3-34-22(33)23(2)11-16(32)26-20-18(23)28-29-19(27-20)17-14-8-6-10-25-21(14)31(30-17)12-13-7-4-5-9-15(13)24/h4-10H,3,11-12H2,1-2H3,(H,26,27,29,32) NWBMXLKFQOXIMK-UHFFFAOYSA-N 258364 US9505786, 2 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 490 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258364&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698187 374883739 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450521 OC1(C(=O)Nc2nc(ncc12)-c1nn(Cc2ccccc2F)c2ncccc12)C(F)(F)C(F)(F)F InChI=1S/C21H12F6N6O2/c22-13-6-2-1-4-10(13)9-33-17-11(5-3-7-28-17)14(32-33)16-29-8-12-15(30-16)31-18(34)19(12,35)20(23,24)21(25,26)27/h1-8,35H,9H2,(H,29,30,31,34) WFRBSRIRCNXQIO-UHFFFAOYSA-N 258365 US9505786, 3 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 2400 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258365&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621368 374883740 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450522 NC1(C(=O)Nc2nc(ncc12)-c1nn(Cc2ccccc2F)c2ncccc12)C(F)(F)C(F)(F)F InChI=1S/C21H13F6N7O/c22-13-6-2-1-4-10(13)9-34-17-11(5-3-7-29-17)14(33-34)16-30-8-12-15(31-16)32-18(35)19(12,28)20(23,24)21(25,26)27/h1-8H,9,28H2,(H,30,31,32,35) XMHKACSUJNRLJF-UHFFFAOYSA-N 258366 US9505786, 4 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1300 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258366&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621519 374883741 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450523 CC1(CC2CC2)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C23H19F2N7O/c1-23(9-12-6-7-12)18-20(28-22(23)33)27-19(30-29-18)17-15-8-14(24)10-26-21(15)32(31-17)11-13-4-2-3-5-16(13)25/h2-5,8,10,12H,6-7,9,11H2,1H3,(H,27,28,30,33) SCPFLRLBQJMUNG-UHFFFAOYSA-N 258420 US9505786, 5 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 260 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258420&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621520 374883787 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450524 C[C@]1(CC2CC2)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C23H19F2N7O/c1-23(9-12-6-7-12)18-20(28-22(23)33)27-19(30-29-18)17-15-8-14(24)10-26-21(15)32(31-17)11-13-4-2-3-5-16(13)25/h2-5,8,10,12H,6-7,9,11H2,1H3,(H,27,28,30,33)/t23-/m1/s1 SCPFLRLBQJMUNG-HSZRJFAPSA-N 258367 US9505786, 5-1 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 350 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258367&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 131953900 350083146 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450525 C[C@@]1(CC2CC2)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C23H19F2N7O/c1-23(9-12-6-7-12)18-20(28-22(23)33)27-19(30-29-18)17-15-8-14(24)10-26-21(15)32(31-17)11-13-4-2-3-5-16(13)25/h2-5,8,10,12H,6-7,9,11H2,1H3,(H,27,28,30,33)/t23-/m0/s1 SCPFLRLBQJMUNG-QHCPKHFHSA-N 258418 US9505786, 5-2 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 250 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258418&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 131953902 350083152 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450526 CC1(COCc2ccccc2)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C27H21F2N7O2/c1-27(15-38-14-16-7-3-2-4-8-16)22-24(32-26(27)37)31-23(34-33-22)21-19-11-18(28)12-30-25(19)36(35-21)13-17-9-5-6-10-20(17)29/h2-12H,13-15H2,1H3,(H,31,32,34,37) MGPASUYXFXCANX-UHFFFAOYSA-N 258368 US9505786, 6 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1100 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258368&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621521 374883742 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450527 CCC1(C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C21H17F2N7O/c1-3-21(2)16-18(26-20(21)31)25-17(28-27-16)15-13-8-12(22)9-24-19(13)30(29-15)10-11-6-4-5-7-14(11)23/h4-9H,3,10H2,1-2H3,(H,25,26,28,31) PZJWPCCZGYGNBE-UHFFFAOYSA-N 258421 US9505786, 7 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 340 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258421&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621522 374883788 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450528 CC[C@@]1(C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C21H17F2N7O/c1-3-21(2)16-18(26-20(21)31)25-17(28-27-16)15-13-8-12(22)9-24-19(13)30(29-15)10-11-6-4-5-7-14(11)23/h4-9H,3,10H2,1-2H3,(H,25,26,28,31)/t21-/m1/s1 PZJWPCCZGYGNBE-OAQYLSRUSA-N 258369 US9505786, 7-1 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 200 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258369&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 131953901 350083147 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450529 CC[C@]1(C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C21H17F2N7O/c1-3-21(2)16-18(26-20(21)31)25-17(28-27-16)15-13-8-12(22)9-24-19(13)30(29-15)10-11-6-4-5-7-14(11)23/h4-9H,3,10H2,1-2H3,(H,25,26,28,31)/t21-/m0/s1 PZJWPCCZGYGNBE-NRFANRHFSA-N 258419 US9505786, 7-2 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 350 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258419&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 131953903 350083153 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450530 COc1ccc(Cn2nc(-c3nnc4c(NC(=O)C4(C)C)n3)c3cc(F)cnc23)cc1 InChI=1S/C21H18FN7O2/c1-21(2)16-18(25-20(21)30)24-17(27-26-16)15-14-8-12(22)9-23-19(14)29(28-15)10-11-4-6-13(31-3)7-5-11/h4-9H,10H2,1-3H3,(H,24,25,27,30) DSTNEGGKBNVMIU-UHFFFAOYSA-N 258370 US9505786, 8 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 150 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258370&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71187383 374883743 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450531 Fc1cnc2n(Cc3ccccc3F)nc(-c3nnc4c(NC(=O)C44CCCC4)n3)c2c1 InChI=1S/C22H17F2N7O/c23-13-9-14-16(30-31(20(14)25-10-13)11-12-5-1-2-6-15(12)24)18-26-19-17(28-29-18)22(21(32)27-19)7-3-4-8-22/h1-2,5-6,9-10H,3-4,7-8,11H2,(H,26,27,29,32) KNQROFKQHXFZRF-UHFFFAOYSA-N 258371 US9505786, 9 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 2000 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258371&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698137 374883744 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450532 Cc1ccc(Cn2nc(-c3nnc4c(NC(=O)C4(C)C)n3)c3cc(F)cnc23)c(F)c1 InChI=1S/C21H17F2N7O/c1-10-4-5-11(14(23)6-10)9-30-19-13(7-12(22)8-24-19)15(29-30)17-25-18-16(27-28-17)21(2,3)20(31)26-18/h4-8H,9H2,1-3H3,(H,25,26,28,31) JSWYKVFQCZUILL-UHFFFAOYSA-N 258372 US9505786, 10 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 15 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258372&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621682 374883745 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450533 COc1cccc(Cn2nc(-c3nnc4c(NC(=O)C4(C)C)n3)c3cc(F)cnc23)c1F InChI=1S/C21H17F2N7O2/c1-21(2)16-18(26-20(21)31)25-17(28-27-16)15-12-7-11(22)8-24-19(12)30(29-15)9-10-5-4-6-13(32-3)14(10)23/h4-8H,9H2,1-3H3,(H,25,26,28,31) LRHJKYPJFDSLBU-UHFFFAOYSA-N 258373 US9505786, 11 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 250 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258373&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621683 374883746 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450534 Cc1cccc(Cn2nc(-c3nnc4c(NC(=O)C4(C)C)n3)c3cc(F)cnc23)c1F InChI=1S/C21H17F2N7O/c1-10-5-4-6-11(14(10)23)9-30-19-13(7-12(22)8-24-19)15(29-30)17-25-18-16(27-28-17)21(2,3)20(31)26-18/h4-8H,9H2,1-3H3,(H,25,26,28,31) XWTRMTNXCPMRGL-UHFFFAOYSA-N 258374 US9505786, 12 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 580 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258374&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621684 374883747 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450535 CCOCCC1(C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C23H21F2N7O2/c1-3-34-9-8-23(2)18-20(28-22(23)33)27-19(30-29-18)17-15-10-14(24)11-26-21(15)32(31-17)12-13-6-4-5-7-16(13)25/h4-7,10-11H,3,8-9,12H2,1-2H3,(H,27,28,30,33) PKLBFKBRXLIUFL-UHFFFAOYSA-N 258375 US9505786, 13 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 660 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258375&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621685 374883748 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450536 CCOc1ccc(cn1)-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C28H24FN7O2/c1-4-38-20-12-11-16(14-31-20)22-21-24(34-27(37)28(21,2)3)33-25(32-22)23-18-9-7-13-30-26(18)36(35-23)15-17-8-5-6-10-19(17)29/h5-14H,4,15H2,1-3H3,(H,32,33,34,37) DVRPLFQKIMUDFC-UHFFFAOYSA-N 258376 US9505786, 14 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 2000 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258376&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621686 374883749 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450537 CC1(C)C(=O)Nc2nc(nc(-c3ccn[nH]3)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C24H19FN8O/c1-24(2)17-19(16-9-11-27-31-16)28-21(29-20(17)30-23(24)34)18-14-7-5-10-26-22(14)33(32-18)12-13-6-3-4-8-15(13)25/h3-11H,12H2,1-2H3,(H,27,31)(H,28,29,30,34) PFWUTVWOUOQIFU-UHFFFAOYSA-N 258377 US9505786, 15 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 40 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258377&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71612650 374883750 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450538 CC1(C)C(=O)Nc2nc(nc(C#CC3CC3)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H21FN6O/c1-26(2)20-19(12-11-15-9-10-15)29-23(30-22(20)31-25(26)34)21-17-7-5-13-28-24(17)33(32-21)14-16-6-3-4-8-18(16)27/h3-8,13,15H,9-10,14H2,1-2H3,(H,29,30,31,34) AJZHAFZTDVROAE-UHFFFAOYSA-N 258378 US9505786, 16 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 410 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258378&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621832 374883751 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450539 CC1(C)C(=O)Nc2nc(nc(CCC3CC3)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H25FN6O/c1-26(2)20-19(12-11-15-9-10-15)29-23(30-22(20)31-25(26)34)21-17-7-5-13-28-24(17)33(32-21)14-16-6-3-4-8-18(16)27/h3-8,13,15H,9-12,14H2,1-2H3,(H,29,30,31,34) PGLDZTYYWDNHFP-UHFFFAOYSA-N 258379 US9505786, 17 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 260 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258379&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621833 374883752 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450540 CC1(C)C(=O)Nc2nc(nc(\C=C/C3CC3)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H23FN6O/c1-26(2)20-19(12-11-15-9-10-15)29-23(30-22(20)31-25(26)34)21-17-7-5-13-28-24(17)33(32-21)14-16-6-3-4-8-18(16)27/h3-8,11-13,15H,9-10,14H2,1-2H3,(H,29,30,31,34)/b12-11- IJENQYUQVYVPFX-QXMHVHEDSA-N 258380 US9505786, 18 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 150 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258380&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698173 374883753 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450541 CC1(C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2nc(ccc12)C(F)(F)F InChI=1S/C21H15F4N7O/c1-20(2)15-17(28-19(20)33)27-16(30-29-15)14-11-7-8-13(21(23,24)25)26-18(11)32(31-14)9-10-5-3-4-6-12(10)22/h3-8H,9H2,1-2H3,(H,27,28,30,33) ZCJFNPXWYHVQBH-UHFFFAOYSA-N 258381 US9505786, 19 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 38 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258381&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698161 374883754 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450542 Cc1nc2n(Cc3ccccc3F)nc(-c3ncc4c(NC(=O)C4(C)C)n3)c2cc1F InChI=1S/C22H18F2N6O/c1-11-16(24)8-13-17(19-25-9-14-18(27-19)28-21(31)22(14,2)3)29-30(20(13)26-11)10-12-6-4-5-7-15(12)23/h4-9H,10H2,1-3H3,(H,25,27,28,31) LCHSXIVSEZCWOA-UHFFFAOYSA-N 258382 US9505786, 20 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 920 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258382&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621835 374883755 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450543 Cc1nc2n(Cc3ccccc3F)nc(-c3nnc4c(NC(=O)C4(C)C)n3)c2cc1F InChI=1S/C21H17F2N7O/c1-10-14(23)8-12-15(17-25-18-16(27-28-17)21(2,3)20(31)26-18)29-30(19(12)24-10)9-11-6-4-5-7-13(11)22/h4-8H,9H2,1-3H3,(H,25,26,28,31) JIAWJXIUNJBDCF-UHFFFAOYSA-N 258383 US9505786, 21 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 22 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258383&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 71621836 374883756 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450544 Cc1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C22H19FN6O/c1-12-16-18(27-21(30)22(16,2)3)26-19(25-12)17-14-8-6-10-24-20(14)29(28-17)11-13-7-4-5-9-15(13)23/h4-10H,11H2,1-3H3,(H,25,26,27,30) DRSNDSVQCJQVFA-UHFFFAOYSA-N 258384 US9505786, 22 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 130 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258384&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698148 374883757 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450545 CC1(CCC=C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H20FN7O/c1-3-4-11-23(2)18-20(27-22(23)32)26-19(29-28-18)17-15-9-7-12-25-21(15)31(30-17)13-14-8-5-6-10-16(14)24/h3,5-10,12H,1,4,11,13H2,2H3,(H,26,27,29,32) FNVZJGOUQHQGTB-UHFFFAOYSA-N 258385 US9505786, 23 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 140 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258385&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698191 374883758 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450546 CC1(C)C(=O)Nc2nc(nc(CNS(C)(=O)=O)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H22FN7O3S/c1-23(2)17-16(11-26-35(3,33)34)27-20(28-19(17)29-22(23)32)18-14-8-6-10-25-21(14)31(30-18)12-13-7-4-5-9-15(13)24/h4-10,26H,11-12H2,1-3H3,(H,27,28,29,32) XKLYCRTYFXFVNH-UHFFFAOYSA-N 258386 US9505786, 24 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 48 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258386&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698175 350083148 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450547 CCOC(=O)C1C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C21H16FN7O3/c1-2-32-21(31)14-16-17(25-20(14)30)24-18(27-26-16)15-12-7-5-9-23-19(12)29(28-15)10-11-6-3-4-8-13(11)22/h3-9,14H,2,10H2,1H3,(H,24,25,27,30) RUEAYDFVNRWXQB-UHFFFAOYSA-N 258387 US9505786, 25 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1500 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258387&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698138 374883759 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450548 CC1(CC(O)=O)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C21H16FN7O3/c1-21(9-14(30)31)16-18(25-20(21)32)24-17(27-26-16)15-12-6-4-8-23-19(12)29(28-15)10-11-5-2-3-7-13(11)22/h2-8H,9-10H2,1H3,(H,30,31)(H,24,25,27,32) LCPWQRCHDXLYEV-UHFFFAOYSA-N 258388 US9505786, 26 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 3400 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258388&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698139 374883760 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450549 CCOC(=O)\C=C\c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H23FN6O3/c1-4-36-19(34)12-11-18-20-22(31-25(35)26(20,2)3)30-23(29-18)21-16-9-7-13-28-24(16)33(32-21)14-15-8-5-6-10-17(15)27/h5-13H,4,14H2,1-3H3,(H,29,30,31,35)/b12-11+ XIQIZZMMICDQMS-VAWYXSNFSA-N 258389 US9505786, 27 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 215 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258389&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698176 374883761 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450550 CC1(CC=C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C22H18FN7O/c1-3-10-22(2)17-19(26-21(22)31)25-18(28-27-17)16-14-8-6-11-24-20(14)30(29-16)12-13-7-4-5-9-15(13)23/h3-9,11H,1,10,12H2,2H3,(H,25,26,28,31) OHWVJENSSIXIJO-UHFFFAOYSA-N 258390 US9505786, 28 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 310 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258390&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698140 374883762 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450551 CC(C)Cc1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C25H25FN6O/c1-14(2)12-18-19-21(30-24(33)25(19,3)4)29-22(28-18)20-16-9-7-11-27-23(16)32(31-20)13-15-8-5-6-10-17(15)26/h5-11,14H,12-13H2,1-4H3,(H,28,29,30,33) BJGYEPVVGULYAT-UHFFFAOYSA-N 258391 US9505786, 29 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 420 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258391&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698149 374883763 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450552 CC1(C)C(=O)Nc2nc(nc(CCCC(F)(F)F)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C25H22F4N6O/c1-24(2)18-17(10-5-11-25(27,28)29)31-21(32-20(18)33-23(24)36)19-15-8-6-12-30-22(15)35(34-19)13-14-7-3-4-9-16(14)26/h3-4,6-9,12H,5,10-11,13H2,1-2H3,(H,31,32,33,36) USGZAYJOYDWKRX-UHFFFAOYSA-N 258392 US9505786, 30 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 130 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258392&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698141 374883764 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450553 CC1(C)C(=O)Nc2nc(nc(CCC(F)(F)F)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C24H20F4N6O/c1-23(2)17-16(9-10-24(26,27)28)30-20(31-19(17)32-22(23)35)18-14-7-5-11-29-21(14)34(33-18)12-13-6-3-4-8-15(13)25/h3-8,11H,9-10,12H2,1-2H3,(H,30,31,32,35) RIRFSAFAYLQOMI-UHFFFAOYSA-N 258393 US9505786, 31 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 260 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258393&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698142 374883765 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450554 CCCc1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C24H23FN6O/c1-4-8-17-18-20(29-23(32)24(18,2)3)28-21(27-17)19-15-10-7-12-26-22(15)31(30-19)13-14-9-5-6-11-16(14)25/h5-7,9-12H,4,8,13H2,1-3H3,(H,27,28,29,32) UBFPILYJJMRTHR-UHFFFAOYSA-N 258394 US9505786, 32 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 110 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258394&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698167 374883766 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450555 CCOC(=O)C1(C)C(=O)Nc2nc(ncc12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H19FN6O3/c1-3-33-22(32)23(2)15-11-26-19(27-18(15)28-21(23)31)17-14-8-6-10-25-20(14)30(29-17)12-13-7-4-5-9-16(13)24/h4-11H,3,12H2,1-2H3,(H,26,27,28,31) JXVSNJGCWLPWCK-UHFFFAOYSA-N 258395 US9505786, 33 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 870 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258395&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698224 374883767 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450556 CC1(C(=O)Nc2nc(ncc12)-c1nn(Cc2ccccc2F)c2ncccc12)c1nncs1 InChI=1S/C22H15FN8OS/c1-22(21-29-26-11-33-21)14-9-25-18(27-17(14)28-20(22)32)16-13-6-4-8-24-19(13)31(30-16)10-12-5-2-3-7-15(12)23/h2-9,11H,10H2,1H3,(H,25,27,28,32) WFJXNYRLQMXAKI-UHFFFAOYSA-N 258396 US9505786, 34 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1200 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258396&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698192 374883768 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450557 Cc1ncc(s1)-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C25H20FN7OS/c1-13-28-11-17(35-13)20-18-21(31-24(34)25(18,2)3)30-22(29-20)19-15-8-6-10-27-23(15)33(32-19)12-14-7-4-5-9-16(14)26/h4-11H,12H2,1-3H3,(H,29,30,31,34) PQYJGQJVGDQIAI-UHFFFAOYSA-N 258397 US9505786, 35 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 120 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258397&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698179 374883769 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450558 Cc1nc(C)c(s1)-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H22FN7OS/c1-13-21(36-14(2)29-13)20-18-22(32-25(35)26(18,3)4)31-23(30-20)19-16-9-7-11-28-24(16)34(33-19)12-15-8-5-6-10-17(15)27/h5-11H,12H2,1-4H3,(H,30,31,32,35) IVTVLJHVIKXXQJ-UHFFFAOYSA-N 258398 US9505786, 36 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1100 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258398&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698229 374883770 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450559 CC(C)c1nc(C)c(s1)-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C28H26FN7OS/c1-14(2)26-31-15(3)22(38-26)21-19-23(34-27(37)28(19,4)5)33-24(32-21)20-17-10-8-12-30-25(17)36(35-20)13-16-9-6-7-11-18(16)29/h6-12,14H,13H2,1-5H3,(H,32,33,34,37) ZPULPBNQXOXFRQ-UHFFFAOYSA-N 258399 US9505786, 37 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 500 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258399&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698144 374883771 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450560 Cc1cc(-c2nc(nc3NC(=O)C(C)(C)c23)-c2nn(Cc3ccccc3F)c3ncccc23)n(C)n1 InChI=1S/C26H23FN8O/c1-14-12-18(34(4)32-14)21-19-22(31-25(36)26(19,2)3)30-23(29-21)20-16-9-7-11-28-24(16)35(33-20)13-15-8-5-6-10-17(15)27/h5-12H,13H2,1-4H3,(H,29,30,31,36) FKZFSASRGUDCNY-UHFFFAOYSA-N 258400 US9505786, 38 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 690 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258400&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698230 374883772 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450561 CC(C)n1ccc(n1)-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C27H25FN8O/c1-15(2)35-13-11-19(33-35)22-20-23(32-26(37)27(20,3)4)31-24(30-22)21-17-9-7-12-29-25(17)36(34-21)14-16-8-5-6-10-18(16)28/h5-13,15H,14H2,1-4H3,(H,30,31,32,37) FPGSKIRMQGIKAR-UHFFFAOYSA-N 258401 US9505786, 39 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 240 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258401&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698193 374883773 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450562 Cn1nccc1-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C25H21FN8O/c1-25(2)18-20(17-10-12-28-33(17)3)29-22(30-21(18)31-24(25)35)19-15-8-6-11-27-23(15)34(32-19)13-14-7-4-5-9-16(14)26/h4-12H,13H2,1-3H3,(H,29,30,31,35) ZZDVOZPNVJMBLV-UHFFFAOYSA-N 258402 US9505786, 40 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 250 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258402&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698145 374883774 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450563 Cn1nc(cc1-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12)C(F)(F)F InChI=1S/C26H20F4N8O/c1-25(2)18-20(16-11-17(26(28,29)30)35-37(16)3)32-22(33-21(18)34-24(25)39)19-14-8-6-10-31-23(14)38(36-19)12-13-7-4-5-9-15(13)27/h4-11H,12H2,1-3H3,(H,32,33,34,39) CSMQCQSKWYNWJM-UHFFFAOYSA-N 258403 US9505786, 41 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1600 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258403&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698151 374883775 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450564 Cn1c(ccc1-c1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12)C#N InChI=1S/C27H21FN8O/c1-27(2)20-22(19-11-10-16(13-29)35(19)3)31-24(32-23(20)33-26(27)37)21-17-8-6-12-30-25(17)36(34-21)14-15-7-4-5-9-18(15)28/h4-12H,14H2,1-3H3,(H,31,32,33,37) RYDGNYJFMMWDJS-UHFFFAOYSA-N 258404 US9505786, 42 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1300 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258404&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698152 374883776 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450565 CCOC(=O)C1(C)C(=O)Nc2nc(nc(I)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H18FIN6O3/c1-3-34-22(33)23(2)15-17(25)27-19(28-18(15)29-21(23)32)16-13-8-6-10-26-20(13)31(30-16)11-12-7-4-5-9-14(12)24/h4-10H,3,11H2,1-2H3,(H,27,28,29,32) JIWAKIJHMDVLLB-UHFFFAOYSA-N 258405 US9505786, 43 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 1750 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258405&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89423243 374883777 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450566 CC1(C)C(=O)Nc2nc(nc(CN)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C22H19F2N7O/c1-22(2)16-15(8-25)27-19(28-18(16)29-21(22)32)17-13-7-12(23)9-26-20(13)31(30-17)10-11-5-3-4-6-14(11)24/h3-7,9H,8,10,25H2,1-2H3,(H,27,28,29,32) MEUYLEYPIIQFNO-UHFFFAOYSA-N 258406 US9505786, 44 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 870 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258406&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698153 374883778 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450567 COCCCc1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C25H25FN6O2/c1-25(2)19-18(11-7-13-34-3)28-22(29-21(19)30-24(25)33)20-16-9-6-12-27-23(16)32(31-20)14-15-8-4-5-10-17(15)26/h4-6,8-10,12H,7,11,13-14H2,1-3H3,(H,28,29,30,33) DITXFYPXHQRDTA-UHFFFAOYSA-N 258407 US9505786, 46 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 120 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258407&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698154 374883779 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450568 CC1(C(=O)NC2CC2)C(=O)Nc2nc(ncc12)-c1nn(CCC(F)(F)F)c2ncccc12 InChI=1S/C20H18F3N7O2/c1-19(17(31)26-10-4-5-10)12-9-25-15(27-14(12)28-18(19)32)13-11-3-2-7-24-16(11)30(29-13)8-6-20(21,22)23/h2-3,7,9-10H,4-6,8H2,1H3,(H,26,31)(H,25,27,28,32) DCXGFUQLEQJJDV-UHFFFAOYSA-N 258408 US9505786, 49 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 4000 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258408&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698231 374883780 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450569 CC1(CC=C)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C22H17F2N7O/c1-3-8-22(2)17-19(27-21(22)32)26-18(29-28-17)16-14-9-13(23)10-25-20(14)31(30-16)11-12-6-4-5-7-15(12)24/h3-7,9-10H,1,8,11H2,2H3,(H,26,27,29,32) PQSPYZJDQKLWNW-UHFFFAOYSA-N 258409 US9505786, 51 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 140 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258409&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 117720383 374883781 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450570 CC1(CC(O)=O)C(=O)Nc2nc(nnc12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C21H15F2N7O3/c1-21(7-14(31)32)16-18(26-20(21)33)25-17(28-27-16)15-12-6-11(22)8-24-19(12)30(29-15)9-10-4-2-3-5-13(10)23/h2-6,8H,7,9H2,1H3,(H,31,32)(H,25,26,28,33) TURSPEQEIQIVTO-UHFFFAOYSA-N 258410 US9505786, 52 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 3900 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258410&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 117720363 374883782 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450571 CCOC(=O)C#Cc1nc(nc2NC(=O)C(C)(C)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C26H21FN6O3/c1-4-36-19(34)12-11-18-20-22(31-25(35)26(20,2)3)30-23(29-18)21-16-9-7-13-28-24(16)33(32-21)14-15-8-5-6-10-17(15)27/h5-10,13H,4,14H2,1-3H3,(H,29,30,31,35) SYRBGAFVPIMBQA-UHFFFAOYSA-N 258411 US9505786, 53 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 41 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258411&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698225 374883783 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450572 CC1(C)C(=O)Nc2nc(nc(CN3CCCC3=O)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C26H23F2N7O2/c1-26(2)20-18(13-34-9-5-8-19(34)36)30-23(31-22(20)32-25(26)37)21-16-10-15(27)11-29-24(16)35(33-21)12-14-6-3-4-7-17(14)28/h3-4,6-7,10-11H,5,8-9,12-13H2,1-2H3,(H,30,31,32,37) GJINZLUHGBYUJW-UHFFFAOYSA-N 258412 US9505786, 54 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 145 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258412&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698157 374883784 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450573 CC1(C)C(=O)Nc2nc(nc(CNS(=O)(=O)C3CC3)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C25H23F2N7O3S/c1-25(2)19-18(11-29-38(36,37)15-7-8-15)30-22(31-21(19)32-24(25)35)20-16-9-14(26)10-28-23(16)34(33-20)12-13-5-3-4-6-17(13)27/h3-6,9-10,15,29H,7-8,11-12H2,1-2H3,(H,30,31,32,35) GWKDSIYNUNGZOW-UHFFFAOYSA-N 258413 US9505786, 55 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 190 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258413&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 117720309 350083149 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450574 CC1(C)C(=O)Nc2nc(nc(CNC(=O)C3CC3)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C26H23F2N7O2/c1-26(2)19-18(11-30-24(36)13-7-8-13)31-22(32-21(19)33-25(26)37)20-16-9-15(27)10-29-23(16)35(34-20)12-14-5-3-4-6-17(14)28/h3-6,9-10,13H,7-8,11-12H2,1-2H3,(H,30,36)(H,31,32,33,37) NKOAZQWIHGKLRM-UHFFFAOYSA-N 258414 US9505786, 56 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 570 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258414&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 117720481 350083150 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450575 CC1(C)C(=O)Nc2nc(nc(CNCC(F)(F)F)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C24H20F5N7O/c1-23(2)17-16(9-30-11-24(27,28)29)32-20(33-19(17)34-22(23)37)18-14-7-13(25)8-31-21(14)36(35-18)10-12-5-3-4-6-15(12)26/h3-8,30H,9-11H2,1-2H3,(H,32,33,34,37) MLACYCAIHMUDGM-UHFFFAOYSA-N 258415 US9505786, 57 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 320 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258415&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698226 350083151 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450576 CC1(C)C(=O)Nc2nc(nc(CCC(F)(F)F)c12)-c1nn(Cc2ccccc2F)c2ncc(F)cc12 InChI=1S/C24H19F5N6O/c1-23(2)17-16(7-8-24(27,28)29)31-20(32-19(17)33-22(23)36)18-14-9-13(25)10-30-21(14)35(34-18)11-12-5-3-4-6-15(12)26/h3-6,9-10H,7-8,11H2,1-2H3,(H,31,32,33,36) KRMVVWKKPPQKSE-UHFFFAOYSA-N 258416 US9505786, 58 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 660 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258416&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698194 374883785 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 450577 CC1(C)C(=O)Nc2nc(nc(CC(N)=O)c12)-c1nn(Cc2ccccc2F)c2ncccc12 InChI=1S/C23H20FN7O2/c1-23(2)17-15(10-16(25)32)27-20(28-19(17)29-22(23)33)18-13-7-5-9-26-21(13)31(30-18)11-12-6-3-4-8-14(12)24/h3-9H,10-11H2,1-2H3,(H2,25,32)(H,27,28,29,33) GZRSMIRKCOHYCH-UHFFFAOYSA-N 258417 US9505786, 61 cGMP-specific 3',5'-cyclic phosphodiesterase Homo sapiens 15 7.5 25.00 C US Patent 10.7270/Q2WS8S6V aid1803627 US9505786 Follmann, M; Stasch, J; Redlich, G; Griebenow, N; Lang, D; Wunder, F; Hubsch, W; Vakalopoulos, A; Tersteegen, A 11/29/2016 11/13/2017 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=258417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5066&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=258417&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase&column=ki&startPg=0&Increment=50&submit=Search 89698159 374883786 1 MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6